Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
CJC-1295/Ipamorelin
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Growth Hormone › CJC-1295/Ipamorelin
← Back to catalog Growth HormoneAvailable

CJC-1295 / Ipamorelin (10 / 20 mg)

GHRH + GHRPSynergy
Presentation
$150 USD
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Synergistic combination that stimulates natural growth hormone release without raising cortisol or prolactin — the "cleanest" secretagogue available.

  • Mechanism: No-DAC GHRH (Mod GRF 1-29) + GHRP (Ipamorelin, ghrelin receptor) — pulsatile synergy. Both receptors known.
  • Evidence: Mostly preclinical; human trials of the combination are lacking.
  • In context: GH/IGF-1 pro-growth (tumor caution).
Research range (SC)
100 mcg + 100–300 mcg per application · 1–2×/day
🔴 Research convention · blend, no study of its own

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundCJC-1295/Ipamorelin
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaAvailable on request
Molecular weightAvailable on request
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

CJC-1295 / Ipamorelin: research profile

This vial combines two peptides that act on growth-hormone secretion through different routes: CJC-1295 without DAC (Mod GRF 1-29), a 29-amino-acid analog of growth-hormone-releasing hormone, and ipamorelin, a synthetic pentapeptide that mimics ghrelin. They come co-lyophilized in equal parts (5 mg + 5 mg, or 10 mg + 10 mg in the 20 mg presentation). It is the most widely used GHRH + secretagogue pairing in the research market.

The rationale for the combination is physiological and documented for both classes: GHRH acts on its pituitary receptor and increases the amount of GH released in each pulse, while ghrelin-receptor (GHSR-1a) agonists amplify that pulse, inhibit somatostatin and also act in the hypothalamus. In humans, co-administration of GHRH and a GHRP produces a GH release greater than the sum of each alone, a synergy described since the 1990s with GHRP-6 and GHRP-2.

What does not exist is a clinical trial of this specific mixture: ipamorelin's evidence is preclinical and from early human studies, and Mod GRF 1-29's is mostly pharmacokinetic. Both have short half-lives (ipamorelin about 2 hours; Mod GRF around 30 minutes), so the GH pattern they generate is pulsatile, not sustained. Like anything that raises GH and IGF-1, it carries the usual theoretical caution in tumor contexts. Renova distributes it for research only.

CJC-1295 / Ipamorelin technical data

CompositionMod GRF (1-29) + Ipamorelin co-lyophilized 1:1 · 10 mg (5+5) or 20 mg (10+10)
Mod GRF (1-29)GHRH(1-29) with D-Ala2, Gln8, Ala15, Leu27 · 3368 g/mol · half-life ≈ 30 min
IpamorelinAib-His-D-2-Nal-D-Phe-Lys-NH2 · 711.9 g/mol · CAS 170851-70-4 · half-life ≈ 2 h
ReceptorsGHRH-R (pituitary) + GHSR-1a (ghrelin receptor)
Mechanism of the pairGHRH raises GH pulse amplitude; the GHSR agonist amplifies it and inhibits somatostatin
EvidenceGHRH + GHRP synergy documented in humans for the classes; no trial of this combination
Ipamorelin profileNo relevant rise in cortisol, prolactin or appetite in studies
Regulatory statusNeither component approved; GHRH and secretagogues on the WADA list (S2)

Questions about CJC-1295 / Ipamorelin

Why combine a GHRH analog with a secretagogue?

Because they act on different receptors of the same somatotroph cell and potentiate each other: GHRH increases how much GH leaves in each pulse, and the ghrelin agonist amplifies the pulse and inhibits somatostatin, the natural brake. In humans GH release with both classes together exceeds the sum of each alone.

What is the difference between CJC-1295 with and without DAC in this blend?

This vial carries the no-DAC version (Mod GRF 1-29), short-acting (about 30 minutes), which generates GH pulses resembling physiological ones. The DAC version binds albumin and lasts days, raising GH continuously; it is not the one in this combination.

What sets ipamorelin apart from other secretagogues like GHRP-6?

Its selectivity. In Novo Nordisk's original studies (1998), ipamorelin released GH without raising ACTH, cortisol or prolactin, unlike GHRP-6 and GHRP-2, and it does not stimulate appetite the way GHRP-6 does. That is why it is the secretagogue that usually accompanies GHRH in research.

Are there clinical trials of CJC-1295 + Ipamorelin?

Not of the combination. There are human studies of each class (GHRH and GHRP) and of their synergy, pharmacokinetic studies of Mod GRF 1-29, and preclinical and early-phase data on ipamorelin. The specific mixture is a research-market practice.

Related reading: CJC-1295 + Ipamorelin: The Most-Studied GH Stack · Peptide Stacking: Synergy, Sequencing, and Combinations

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Delivery in the Dominican Republic

📦 Santo Domingo: approx. 2–4 business hours🚚 Nationwide: approx. 6–12 business hours · RD$400❄️ Cold chain 2–8°C✓ No minimum order

Zones: Santo Domingo · Santiago · Punta Cana · La Romana

Frequently asked questions

How does CJC-1295 / Ipamorelin arrive in the Dominican Republic?

Delivery in Santo Domingo in about 2–4 business hours and nationwide in about 6–12 business hours by courier with tracking (RD$400). Reconstituted compounds travel cold-chain (2–8°C) in thermal packaging.

Can I verify the purity of CJC-1295 / Ipamorelin?

We publish Janoshik Analytical certificates of analysis (HPLC + mass spectrometry) at renovapeptides.do/coa/ — review the library before ordering.

How do I pay?

Orders are confirmed over WhatsApp. Payment: Payment Link (PayPal — card, Apple Pay or Venmo), bank transfer, or pay on delivery in Santo Domingo (cash or transfer on receipt).

Is there a minimum order or volume discount?

There is no minimum order. Automatic cart discounts: same-product volume (3+ units 15%, 5+ 25%, 10+ 40%) and Mix & Match across different products (3+ items 10%, 5+ 15%, 7+ 20%; not applicable to Retatrutide or Tirzepatide). The better of the two applies per product; bacteriostatic water is excluded and promo codes can't be combined.

📖 Full guide: CJC-1295 + Ipamorelin: The Most-Studied GH Stack

Questions? Write us

Your Order

Your cart is empty